Vendas Alterar Data
Acadia Pharmaceuticals USD 342M 34.04M 2026-09
Agios Pharmaceuticals USD 55.38M 10.64M 2026-09
Akebia Therapeutics USD 57.62M 1.14M 2025-12
ALKERMES USD 480.13M 15.88M 2026-09
Alnylam Pharmaceuticals USD 1.46B 170M 2026-09
Amgen USD 10.4B 300M 2026-09
Biogen USD 2.8B 60M 2026-09
BioMarin Pharmaceutical USD 1.03B 40M 2026-09
Exelixis USD 658.69M 30M 2026-09
Incyte USD 1.56B 110M 2026-09
Ionis Pharmaceuticals USD 243M 25M 2026-09
MacroGenics USD 32.83M 12.03M 2026-06
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neurocrine Biosciences USD 1.12B 161M 2026-09
Prothena USD 1.01M 50.07M 2026-06
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Ultragenyx Pharmaceutical USD 173M 41M 2026-09
Vertex Pharmaceuticals USD 3.44B 110M 2026-09